Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Ladanyi

Showing results (61-70 of 569) with videos related to

Pageof 57
Sort By:
The Journal of Molecular Diagnostics : JMD|October 14, 2008
The evolution of molecular genetic pathology: advancing 20th-century diagnostic methods into potent tools for the new millenniumMark E Sobel, Adam Bagg, Angela M Caliendo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor geneVioletta Barbashina, Paulo Salazar, Eric C Holland, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 18, 2020
Characterization of TP53-wildtype tubo-ovarian high-grade serous carcinomas: rare exceptions to the binary classification of ovarian serous carcinomaM Herman Chui, Amir Momeni Boroujeni, Diana Mandelker, et al.
JCO Precision Oncology|July 10, 2025
Clinical Significance of <i>TERT</i> Promoter Mutations in NeuroblastomaNatasha Persaud, Gunes Gundem, Brian H Kushner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 12, 2017
<i>RASA1</i> and <i>NF1</i> are Preferentially Co-Mutated and Define A Distinct Genetic Subset of Smoking-Associated Non-Small Cell Lung Carcinomas Sensitive to MEK InhibitionTakuo Hayashi, Patrice Desmeules, Roger S Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
EWS-CREB1: a recurrent variant fusion in clear cell sarcoma--association with gastrointestinal location and absence of melanocytic differentiationCristina R Antonescu, Khedoudja Nafa, Neil H Segal, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 27, 2013
KRAS mutations are associated with solid growth pattern and tumor-infiltrating leukocytes in lung adenocarcinomaNatasha Rekhtman, Daphne C Ang, Gregory J Riely, et al.
The American Journal of Surgical Pathology|December 10, 2008
Melanotic Xp11 translocation renal cancers: a distinctive neoplasm with overlapping features of PEComa, carcinoma, and melanomaPedram Argani, Sebastian Aulmann, Zarir Karanjawala, et al.
Journal of Cutaneous Pathology|November 3, 2022
A novel case of cutaneous myxoid spindle cell neoplasm with FMR1-ALK gene fusion and CD34/S100 co-expressionIsrael Kasago, Umut Aypar, Purvil Sukhadia, et al.
Oncogene|August 15, 2003
A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23)Pedram Argani, Man Yee Lui, Jérôme Couturier, et al.
Pageof 57

Showing results (61-70 of 569) with videos related to

Sort By:
Pageof 57
The Journal of Molecular Diagnostics : JMD|October 14, 2008
The evolution of molecular genetic pathology: advancing 20th-century diagnostic methods into potent tools for the new millenniumMark E Sobel, Adam Bagg, Angela M Caliendo, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2005
Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor geneVioletta Barbashina, Paulo Salazar, Eric C Holland, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 18, 2020
Characterization of TP53-wildtype tubo-ovarian high-grade serous carcinomas: rare exceptions to the binary classification of ovarian serous carcinomaM Herman Chui, Amir Momeni Boroujeni, Diana Mandelker, et al.
JCO Precision Oncology|July 10, 2025
Clinical Significance of <i>TERT</i> Promoter Mutations in NeuroblastomaNatasha Persaud, Gunes Gundem, Brian H Kushner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 12, 2017
<i>RASA1</i> and <i>NF1</i> are Preferentially Co-Mutated and Define A Distinct Genetic Subset of Smoking-Associated Non-Small Cell Lung Carcinomas Sensitive to MEK InhibitionTakuo Hayashi, Patrice Desmeules, Roger S Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
EWS-CREB1: a recurrent variant fusion in clear cell sarcoma--association with gastrointestinal location and absence of melanocytic differentiationCristina R Antonescu, Khedoudja Nafa, Neil H Segal, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 27, 2013
KRAS mutations are associated with solid growth pattern and tumor-infiltrating leukocytes in lung adenocarcinomaNatasha Rekhtman, Daphne C Ang, Gregory J Riely, et al.
The American Journal of Surgical Pathology|December 10, 2008
Melanotic Xp11 translocation renal cancers: a distinctive neoplasm with overlapping features of PEComa, carcinoma, and melanomaPedram Argani, Sebastian Aulmann, Zarir Karanjawala, et al.
Journal of Cutaneous Pathology|November 3, 2022
A novel case of cutaneous myxoid spindle cell neoplasm with FMR1-ALK gene fusion and CD34/S100 co-expressionIsrael Kasago, Umut Aypar, Purvil Sukhadia, et al.
Oncogene|August 15, 2003
A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23)Pedram Argani, Man Yee Lui, Jérôme Couturier, et al.
Pageof 57